Understanding Processes, Outcomes, and Contexts in Medication Adherence: The Medication Adherence Context and Outcomes (MACO) Framework

被引:11
|
作者
Ellis, Rebecca J. Bartlett [1 ,3 ]
Haase, Joan E. [1 ]
Ruppar, Todd M. [2 ]
机构
[1] Indiana Univ, Sch Nursing, Sci Nursing Care, Indianapolis, IN 46202 USA
[2] Rush Univ, Coll Nursing, Dept Adult Hlth & Gerontol Nursing, Chicago, IL USA
[3] Indiana Univ, Sch Nursing, Dept Sci Nursing Care, 600 Barnhill Dr,E423, Indianapolis, IN 46202 USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2023年 / 17卷
基金
美国国家卫生研究院;
关键词
medication management; health behavior; implementation; ecological models; medication adherence; TRIALS;
D O I
10.2147/PPA.S387813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Poor medication adherence is a significant problem, yet interventions to improve it have been largely ineffective. Existing ecological models indicate that adherence is multi-dimensional; however, they do not reflect understanding of context-specific processes and how they lead to adherence outcomes. A framework that reflects context-specific processes is important because it could be used to inform context-specific intervention delivery and measure associated adherence outcomes. The purpose of this paper is to describe the Medication Adherence Context and Outcomes (MACO) framework, which includes contexts (ie, clinics, pharmacies, and home) and context-specific processes (ie, shared decision-making, prescription filling strategies, home medication management) that lead to adherence outcomes (initiation, implementation, discontinuation, and persistence). The Medication and Adherence Contexts and Outcomes (MACO) framework was iteratively developed between 2015 and 2018 based on theory, practice, and research and combining patient experience journey mapping to chronologically describe the environmental contexts and actions (processes) that occur within the contexts and how they contribute to medication adherence as outcome. The three distinct yet interrelated contexts described in the MACO framework are 1) clinical encounters, 2) pharmacy encounters, and 3) day-to-day home management. Within these contexts are specific medication management actions that occur (processes) in order to produce adherencerelated outcomes (initiation, implementation, and discontinuation/persistence). The MACO framework distinguishes context-specific processes and outcomes. The MACO framework may be useful to understand at which point(s) along the continuum people experience problems with managing medications. This understanding is potentially useful for developing and delivering context-specific interventions that are based on processes that underlie nonadherence and selecting adherence measures appropriate for the contexts.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 50 条
  • [21] Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes
    Wang, Chia-shi
    Troost, Jonathan P.
    Wang, Yujie
    Greenbaum, Larry A.
    Gibson, Keisha
    Trachtman, Howard
    Srivastava, Tarak
    Reidy, Kimberly
    Kaskel, Frederick
    Sethna, Christine B.
    Meyers, Kevin
    Dell, Katherine M.
    Tran, Cheryl L.
    Hingorani, Sangeeta
    Lemley, Kevin, V
    Lin, Jen-Jar
    Gipson, Debbie S.
    PEDIATRIC NEPHROLOGY, 2022, 37 (07) : 1585 - 1595
  • [22] COMPARISON OF MEDICATION ADHERENCE AND OUTCOMES IN SPRINT INDIA TRIAL
    Verma, S. J.
    Pandian, J.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 8 - 8
  • [23] Schizophrenia and antipsychotic medication - Better adherence, better outcomes?
    Staring, A. B. P.
    Van der Gaag, M.
    Mulder, C. L.
    SCHIZOPHRENIA RESEARCH, 2013, 151 (1-3) : 296 - 297
  • [24] Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes
    Chia-shi Wang
    Jonathan P Troost
    Yujie Wang
    Larry A Greenbaum
    Keisha Gibson
    Howard Trachtman
    Tarak Srivastava
    Kimberly Reidy
    Frederick Kaskel
    Christine B Sethna
    Kevin Meyers
    Katherine M Dell
    Cheryl L Tran
    Sangeeta Hingorani
    Kevin V Lemley
    Jen-Jar Lin
    Debbie S Gipson
    Pediatric Nephrology, 2022, 37 : 1585 - 1595
  • [25] Medication Adherence And Predictors Of Medication Adherence In Asthma
    Marott, J. L.
    Ingebrigtsen, T. S.
    Lange, P.
    Nordestgaard, B. G.
    Dahl, M.
    Vestbo, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [26] Medication Adherence: Expanding the Conceptual Framework
    Krousel-Wood, Marie
    Craig, Leslie S.
    Peacock, Erin
    Zlotnick, Emily
    O'Connell, Samantha
    Bradford, David
    Shi, Lizheng
    Petty, Richard
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (09) : 895 - 909
  • [27] MEDICATION ADHERENCE AND LONGITUDINAL PULMONARY OUTCOMES IN CHILDREN AND ADULTS WITH CF
    Quon, B. S.
    Wilcox, P.
    Cho, E.
    Chilvers, M.
    Kendrick, J.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 360 - 360
  • [28] Relationship between medication adherence and treatment outcomes: The COMBINE study
    Zweben, Allen
    Pettinati, Helen M.
    Weiss, Roger D.
    Youngblood, Marston
    Cox, Christine E.
    Mattson, Margaret E.
    Gorroochurn, Prakash
    Ciraulo, Domenic
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2008, 32 (09) : 1661 - 1669
  • [29] Medication costs, adherence, and health outcomes among Medicare beneficiaries
    Mojtabai, R
    Olfson, M
    HEALTH AFFAIRS, 2003, 22 (04) : 220 - 229
  • [30] Medication adherence and health outcomes among asthma patients in Slovenia
    Janezic, Ana
    Locatelli, Igor
    Kos, Mitja
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (02) : 415 - 415